hydroxyindoleacetic acid has been researched along with Hypertension, Malignant in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lachhein, L | 1 |
| Schütz, J | 1 |
1 other study available for hydroxyindoleacetic acid and Hypertension, Malignant
| Article | Year |
|---|---|
[Simple test for pheochromocytoma as well as neuroblastoma and small intestine carcinoids. Analysis of 3-methoxy-4-hydroxymandelic acid, 3-methoxy-4-hydroxyphenylacetic acid and 5-hydroxy-indoleacetic acid in urine by chromatoelectrophoresis].
Topics: Antihypertensive Agents; Carcinoid Tumor; Chromatography; Electrophoresis; Humans; Hydroxyindoleacet | 1967 |